Gene · 7498
Papers4,562
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,562
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparative proteomic analysis of human milk fat globules and paired membranes and mouse milk fat globules identifies core cellular systems contributing to mammary lipid trafficking and secretion. | Front Mol Biosci | 2023 | 38169886 | PubTator, text mining | PubMed |
| The Metabolic Score for Insulin Resistance Index is Superior to the Triglyceride and Glucose Index in Identifying Nonalcoholic Fatty Liver Disease in Hyperuricemia Subjects. | Diabetes Metab Syndr Obes | 2023 | 38169634 | PubTator, text mining | PubMed |
| Tibetan Plateau yak milk: A comprehensive review of nutritional values, health benefits, and processing technology. | Food Chem X | 2023 | 38144800 | PubTator, text mining | PubMed |
| Nitric Oxide in the Field: Prevalence and Use of Nitrates by Dietitians and Nutritionists in Spanish Elite Soccer. | Nutrients | 2023 | 38140386 | PubTator, text mining | PubMed |
| Management of Pediatric Urolithiasis in an Italian Tertiary Referral Center: A Retrospective Analysis. | Medicina (Kaunas) | 2023 | 38138268 | PubTator, text mining | PubMed |
| Dysuricemia. | Biomedicines | 2023 | 38137389 | PubTator, text mining | PubMed |
| The Role of Trace Elements in Cardiovascular Diseases. | Toxics | 2023 | 38133357 | PubTator, text mining | PubMed |
| Naringenin prevents non-alcoholic steatohepatitis by modulating the host metabolome and intestinal microbiome in MCD diet-fed mice. | Food Sci Nutr | 2023 | 38107095 | PubTator, text mining | PubMed |
| Neuroprotective Effects and Therapeutic Potential of Dichloroacetate: Targeting Metabolic Disorders in Nervous System Diseases. | Int J Nanomedicine | 2023 | 38106446 | PubTator, text mining | PubMed |
| TCM and related active compounds in the treatment of gout: the regulation of signaling pathway and urate transporter. | Front Pharmacol | 2023 | 38094893 | PubTator, text mining | PubMed |
| 2,8-Dihydroxyadenine nephrolithiasis with chronic kidney disease in children: A case report and review of literature. | Urol Case Rep | 2023 | 38074799 | PubTator, text mining | PubMed |
| Progress and Challenges of Messenger RNA Vaccines in the Therapeutics of NSCLC. | Cancers (Basel) | 2023 | 38067293 | PubTator, text mining | PubMed |
| Network pharmacology and bioinformatics to identify the molecular mechanisms of Gleditsiae Spina against colorectal cancer. | Curr Res Toxicol | 2023 | 38059131 | PubTator, text mining | PubMed |
| Energy metabolic reprogramming regulates programmed cell death of renal tubular epithelial cells and might serve as a new therapeutic target for acute kidney injury. | Front Cell Dev Biol | 2023 | 38054182 | PubTator, text mining | PubMed |
| The dysregulation of immune cells induced by uric acid: mechanisms of inflammation associated with hyperuricemia and its complications. | Front Immunol | 2023 | 38053999 | PubTator, text mining | PubMed |
| Reactive oxygen species (ROS) scavenging biomaterials for anti-inflammatory diseases: from mechanism to therapy. | J Hematol Oncol | 2023 | 38037103 | PubTator, text mining | PubMed |
| Redox imbalance in patients with heart failure and ICD/CRT-D intervention. Can it be an underappreciated and overlooked arrhythmogenic factor? A first preliminary clinical study. | Front Physiol | 2023 | 38028798 | PubTator, text mining | PubMed |
| Chitosan-encapsulated naringenin promotes ROS mediated through the activation of executioner caspase-3. | Med Oncol | 2023 | 38017323 | PubTator, text mining | PubMed |
| Therapeutics to Treat Psychiatric and Neurological Disorders: A Promising Perspective from Algerian Traditional Medicine. | Plants (Basel) | 2023 | 38005756 | PubTator, text mining | PubMed |
| Advancing Our Understanding of Pyranopterin-Dithiolene Contributions to Moco Enzyme Catalysis. | Molecules | 2023 | 38005178 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7498/papers?page=17